DK0975235T3 - Ernæringssammensætninger indeholdende oligosaccharider - Google Patents

Ernæringssammensætninger indeholdende oligosaccharider

Info

Publication number
DK0975235T3
DK0975235T3 DK98912118T DK98912118T DK0975235T3 DK 0975235 T3 DK0975235 T3 DK 0975235T3 DK 98912118 T DK98912118 T DK 98912118T DK 98912118 T DK98912118 T DK 98912118T DK 0975235 T3 DK0975235 T3 DK 0975235T3
Authority
DK
Denmark
Prior art keywords
lacto
compositions containing
nutritional compositions
containing oligosaccharides
fucopentaose
Prior art date
Application number
DK98912118T
Other languages
English (en)
Other versions
DK0975235T4 (da
Inventor
Pedro A Prieto
Stephen J Kirchner
Renee M Erney
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25253688&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0975235(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of DK0975235T3 publication Critical patent/DK0975235T3/da
Application granted granted Critical
Publication of DK0975235T4 publication Critical patent/DK0975235T4/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00Food or edible material: processes, compositions, and products
    • Y10S426/801Pediatric

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Dairy Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98912118.1T 1997-03-31 1998-03-30 Ernæringssammensætninger indeholdende oligosaccharider DK0975235T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/829,157 US6045854A (en) 1997-03-31 1997-03-31 Nutritional formulations containing oligosaccharides
PCT/US1998/006216 WO1998043494A1 (en) 1997-03-31 1998-03-30 Nutritional formulations containing oligosaccharides

Publications (2)

Publication Number Publication Date
DK0975235T3 true DK0975235T3 (da) 2006-10-02
DK0975235T4 DK0975235T4 (da) 2014-03-31

Family

ID=25253688

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98912118.1T DK0975235T4 (da) 1997-03-31 1998-03-30 Ernæringssammensætninger indeholdende oligosaccharider

Country Status (12)

Country Link
US (2) US6045854A (da)
EP (1) EP0975235B2 (da)
JP (2) JP4863236B2 (da)
AT (1) ATE326862T1 (da)
CA (1) CA2285065C (da)
DE (1) DE69834633T3 (da)
DK (1) DK0975235T4 (da)
ES (1) ES2265161T5 (da)
MX (1) MX210206B (da)
NO (1) NO315682B1 (da)
PT (1) PT975235E (da)
WO (1) WO1998043494A1 (da)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19701382A1 (de) * 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
US6329170B1 (en) * 1999-04-23 2001-12-11 Northwest Hospital Nucleic acids and proteins of a rat ganglioside GM1-specific α1→2fucosyltransferase and uses thereof
DE19958985A1 (de) * 1999-12-07 2001-06-13 Nutricia Nv Oligosaccharidmischung
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
DE10147100A1 (de) * 2001-09-25 2003-04-17 Numico Res B V Antiinfektive Kohlenhydrate
DE10204000A1 (de) * 2002-02-01 2003-08-14 Nutricia Nv Sialysierte Kohlenhydrate
AU2003273206B2 (en) * 2002-05-31 2009-08-20 Children's Hospital Medical Center Method, composition and kit for antigenic binding of Norwalk-Like viruses
US7977098B2 (en) * 2002-05-31 2011-07-12 Children's Hospital Medical Center Antigenic binding patterns of norovirus to human histo-blood group antigens
DE60327211D1 (de) * 2002-06-28 2009-05-28 Glykos Finland Oy Therapeutische zusammensetzungen zur verwendung bei der prophylaxe oder behandlung von durchfall
EP1643862A1 (en) * 2003-06-24 2006-04-12 University of Kansas Medical Center Infant formula
EP1689348B1 (en) * 2003-12-05 2013-05-15 Children's Hospital Medical Center Oligosaccharide compositions and use thereof in the treatment of infection
ES1056525Y (es) * 2004-01-13 2004-07-16 Perez Alfredo Pineiro Halador de tres rodillos para redes y aparejos de pesca.
ATE361101T1 (de) * 2004-08-24 2007-05-15 Nutricia Nv Nahrungszusammensetzung die unverdauliche oligosaccharide enthält
WO2007090894A1 (en) * 2006-02-10 2007-08-16 Nestec S.A. Oligosaccharide mixture
US20110152263A1 (en) * 2006-11-16 2011-06-23 Xi Jiang Composition and method for inhibiting norovirus infection
US8197872B2 (en) * 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
JP5766947B2 (ja) 2007-09-07 2015-08-19 チルドレンズ ホスピタル メディカル センター 臨床サンプルにおける分泌性のルイス抗原およびシアル化抗原のレベルの疾患リスクの予測指標としての使用
EP2060257A1 (en) * 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
PT2217246E (pt) * 2007-11-08 2015-02-10 Nestec Sa Utilização de oligossacáridos contendo n-acetil-lactosamina para maturação de respostas imunes em recém-nascidos
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
BRPI0909289A2 (pt) 2008-03-14 2015-08-04 Nestec Sa Mistura simbiótica
US8927027B2 (en) 2008-12-02 2015-01-06 Prolacta Bioscience Human milk permeate compositions and methods of making and using same
CN102239173A (zh) * 2008-12-19 2011-11-09 动量制药公司 与修饰的聚糖相关的方法
CN107043408B (zh) 2009-06-09 2021-02-09 儿童医院医疗中心 抗原-诺罗病毒p-结构域单体和二聚体,抗原-诺罗病毒p-粒子分子,及其制备和应用方法
ES2651067T3 (es) 2009-07-06 2018-01-24 Children's Hospital Medical Center Inhibición de la inflamación con oligosacáridos de la leche
EP2662084A1 (en) * 2009-07-15 2013-11-13 N.V. Nutricia Mixture of non-digestible oligosaccharides for stimulating the immune system
CN102946742A (zh) * 2010-04-27 2013-02-27 N·V·努特里奇亚 人乳寡糖在婴儿营养物中的用途
WO2011136637A1 (en) 2010-04-27 2011-11-03 N.V. Nutricia Use of human milk oligosaccharides in infant nutrition
EP2576578B1 (en) * 2010-06-01 2018-09-19 Glycom A/S Polymorphs of 2'-o-fucosyllactose and producing thereof
EP2465509A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating acute respiratory tract infections
EP2454948A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
SG191798A1 (en) * 2010-12-31 2013-08-30 Abbott Lab Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
MY171620A (en) 2010-12-31 2019-10-21 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers or children using human milk oligosaccharides
NZ612504A (en) 2010-12-31 2015-02-27 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
ES2667393T3 (es) 2010-12-31 2018-05-10 Abbott Laboratories Oligosacáridos de leche humana para modular inflamación
WO2012092160A2 (en) * 2010-12-31 2012-07-05 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
WO2012092157A2 (en) * 2010-12-31 2012-07-05 Abbott Laboratories Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
NZ613180A (en) 2010-12-31 2015-02-27 Abbott Lab Methods of using human milk oligosaccharides for improving airway respiratory health
WO2012092153A1 (en) 2010-12-31 2012-07-05 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
EP2707379A4 (en) * 2011-05-13 2014-10-08 Glycosyn LLC USE OF PURIFIED 2'-FUCOSYLLACTOSIS, 3-FUCOSYLLACTOSIS AND LACTODIFUCOTETRAOSE AS PREBIOTICS
EP2522232A1 (en) * 2011-05-13 2012-11-14 Nestec S.A. Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof
EP2526784A1 (en) 2011-05-24 2012-11-28 Nestec S.A. Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition
US11446316B2 (en) * 2011-07-22 2022-09-20 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CN113662199A (zh) * 2011-08-29 2021-11-19 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖
US9834574B2 (en) * 2012-11-13 2017-12-05 Glycom A/S Crystalline 3-O-fucosyllactose
WO2014090261A1 (en) * 2012-12-14 2014-06-19 Glycom A/S Mixture of fucosylate lactoses
EP2745705A1 (en) * 2012-12-18 2014-06-25 Abbott Laboratories Nutritional use of human milk oligosaccharides
US10626460B2 (en) 2013-02-21 2020-04-21 Children's Hospital Medical Center Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
EP2999358B1 (en) 2013-05-22 2021-07-07 Glycom A/S Synthetic mixture of oligosaccharides for the treating a microbiota of a mammal
US9321803B2 (en) 2013-07-12 2016-04-26 Children's Hospital Medical Center Compositions and methods for inhibiting norovirus infection
EP3111942B1 (en) 2013-11-15 2021-01-06 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of urt infections in infants or young children at risk
CA3179163A1 (en) 2014-04-08 2015-10-15 Abbott Laboratories Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides
BR112017003920A2 (pt) * 2014-09-25 2017-12-12 Nestec Sa sistema de fórmulas infantis para lactentes com teores adaptativos de oligossacarídeos de leite humano (hmos)
PL3209673T5 (pl) 2014-10-24 2023-10-23 Glycom A/S Mieszaniny hmo
WO2016066735A1 (en) 2014-10-31 2016-05-06 Nestec S.A. Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition
WO2016139333A1 (en) 2015-03-05 2016-09-09 Nestec S.A. Compositions for use in the prevention or treatment of gastrointestinal infections/inflammations in infants or young children
AU2016227595B2 (en) * 2015-03-05 2020-08-27 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of otitis or bronchitis in infants or young children
WO2016176484A1 (en) 2015-04-28 2016-11-03 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
US20180220690A1 (en) * 2015-08-04 2018-08-09 Nestec S.A. Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
MX2018007124A (es) 2015-12-15 2018-09-07 Nestec Sa Mezcla de hmo.
AU2017211272B2 (en) * 2016-01-26 2022-04-21 Société des Produits Nestlé S.A. Human milk oligosaccharides for health benefits by prevention of premature adiposity rebound
AU2017211270B2 (en) * 2016-01-26 2022-12-08 Société des Produits Nestlé S.A. Human milk oligosaccharides against later in life excessive fat mass accumulation and related health disorders
US20200054035A1 (en) * 2016-09-19 2020-02-20 Prolacta Bioscience, Inc. Purified human milk oligosaccharides compositions
US10980269B2 (en) * 2016-12-12 2021-04-20 Mead Johnson Nutrition Company Protein hydrolysates and methods of making same
CA3053522A1 (en) 2017-03-28 2018-10-04 Children's Hospital Medical Center Norovirus s particle based vaccines and methods of making and using same
EP3629770A1 (en) 2017-05-24 2020-04-08 Société des Produits Nestlé S.A. Composition comprising oligofructose (of) for use in the improvement of short term memory and other cognitive benefits
CN110799045A (zh) 2017-05-24 2020-02-14 雀巢产品有限公司 用于改善短期记忆和其他认知益处的包含人乳低聚糖(hmo)的组合物
WO2019008105A1 (en) 2017-07-07 2019-01-10 Nestec S.A. FORTIFYING HUMAN MILK
US20200221749A1 (en) 2017-07-07 2020-07-16 Societe Des Produits Nestle S.A. Human milk fortifier
EP3648617A1 (en) 2017-07-07 2020-05-13 Société des Produits Nestlé S.A. Human milk fortifier
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
WO2019160922A1 (en) * 2018-02-19 2019-08-22 Dupont Nutrition Biosciences Aps Process for spray drying fucosyllactose solutions and related product compositions
EP3546060A1 (en) * 2018-03-27 2019-10-02 DuPont Nutrition Biosciences ApS Process for spray drying fucosyllactose solutions and related product compositions
BR112020023102A2 (pt) 2018-06-25 2021-02-02 Société des Produits Nestlé S.A. uso de oligossacarídeos de leite humano, e composição que compreende os mesmos
MX2020012783A (es) 2018-06-25 2021-01-20 Nestle Sa Composicion que comprende oligosacaridos de la leche humana para uso en la mejora, refuerzo, promocion o modulacion de una funcion serotonergica en el sistema nervioso central.
BR112021010202A2 (pt) * 2018-12-20 2021-08-17 Société des Produits Nestlé S.A. composição fortificante de leite humano
CN113613510B (zh) * 2019-06-04 2024-04-12 N·V·努特里奇亚 包含2’岩藻糖基乳糖和3’半乳糖基乳糖的营养组合物
WO2021015977A1 (en) * 2019-07-23 2021-01-28 Dupont Nutrition Biosciences Aps Oral healthcare treatment and related compositions
ES1240969Y (es) * 2019-09-18 2020-07-30 Jennewein Biotechnologie Gmbh Composiciones de cereales que contienen oligosacaridos de la leche humana
GB2590375B (en) * 2019-12-11 2024-05-08 Mjn Us Holdings Llc Staged nutritional compositions containing human milk oligosaccharides and uses thereof
TW202233201A (zh) * 2020-12-16 2022-09-01 荷蘭商弗里斯蘭康必奶荷蘭有限公司 包含LNFP III和LSTa的合成組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5951264B2 (ja) * 1981-11-30 1984-12-13 雪印乳業株式会社 オリゴ糖含有粉末の製造方法
DD273543A3 (de) * 1987-09-14 1989-11-22 Univ Rostock Verfahren zur herstellung von saeuglings- und diaetnahrungen mit hypoantigener, bifidogener wirkung
SE462134B (sv) * 1987-10-22 1990-05-14 Biocarb Ab Livsmedel innehaallande lacto-n-tetraos och foerfarande foer dess framstaellning
DE3876986D1 (de) * 1988-07-07 1993-02-04 Milupa Ag Verfahren zur enzymatischen herstellung von bifidogener saeuglings- und diaetnahrung.
US5095106A (en) * 1989-07-25 1992-03-10 Colgate-Palmolive Olgiosaccharide inhibition of Streptococcus pyogenes adhesion
US5180674A (en) * 1990-04-16 1993-01-19 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5021245A (en) * 1990-05-22 1991-06-04 Abbott Laboratories Infant formula containing a soy polysaccharide fiber source
JPH09503905A (ja) * 1993-07-15 1997-04-22 ネオゼ ファーマシューティカルス 糖組成物の合成方法
US5750176A (en) * 1994-03-09 1998-05-12 Abbott Laboratories Transgenic non-human mammal milk comprising 2'-fucosyl-lactose
JPH0838064A (ja) * 1994-07-26 1996-02-13 Meiji Seika Kaisha Ltd 有害細菌の感染を予防する飼料
US5545553A (en) * 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US5827526A (en) * 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans

Also Published As

Publication number Publication date
JP4863236B2 (ja) 2012-01-25
EP0975235B1 (en) 2006-05-24
JP2001517949A (ja) 2001-10-09
DK0975235T4 (da) 2014-03-31
US6045854A (en) 2000-04-04
PT975235E (pt) 2006-10-31
ES2265161T3 (es) 2007-02-01
MX210206B (es) 2002-09-06
NO315682B1 (no) 2003-10-13
WO1998043494A1 (en) 1998-10-08
CA2285065A1 (en) 1998-10-08
JP2012036192A (ja) 2012-02-23
ES2265161T5 (es) 2014-03-24
DE69834633T2 (de) 2007-05-03
EP0975235B2 (en) 2014-01-15
NO994621L (no) 1999-09-23
MX9908953A (es) 2000-01-31
CA2285065C (en) 2011-07-19
EP0975235A1 (en) 2000-02-02
DE69834633D1 (de) 2006-06-29
NO994621D0 (no) 1999-09-23
ATE326862T1 (de) 2006-06-15
DE69834633T3 (de) 2014-05-08
US6146670A (en) 2000-11-14

Similar Documents

Publication Publication Date Title
DK0975235T3 (da) Ernæringssammensætninger indeholdende oligosaccharider
NO20001105L (no) Transgene pattedyr som danner oligosakkarider i melken
PE44895A1 (es) Compuesto derivado de benzotiofeno que puede inhibir la perdida osea y disminuir el colesterol en suero
IL118047A (en) Sulfated oligosaccharides pharmaceutical compositions containing them and preparation of sulfated hexopyranose homooligosaccharides
FI973828A0 (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
CA2339765A1 (en) Compounds and compositions for delivering active agents
YU23599A (sh) Stabilizovani antihistaminski sirup
BG102259A (en) Compostions with controlled paroxetine release
CA2338358A1 (en) Compounds and compositions for delivering active agents
NZ333475A (en) Microemulsion all purpose liquid cleaning compositions containing 0.05% to 5.0% of an acaricidal agent
EP0831871A4 (en) SIMILAR FACTOR TO RELAXIN, ITS METHODS AND USES
WO1999017711A3 (en) Autophobic hairspray compositions
AU571265B2 (en) Oxopyrimidine derivatives
WO1999006388A3 (en) Pharmaceutical compounds isolated from aristolochia taliscana
CA2183747A1 (en) Detergent Compositions
BG103306A (en) Liquid allendronate compositions
HUP9801133A3 (en) 1,2,4-triazole-derivatives, fungicide compositions containing these compounds as active ingredients
EP1075796A4 (en) SWEETENER COMPOSITIONS
IL127851A0 (en) Inhibition of TNF activity
YU23498A (sh) Herbicidni 3,5-difluoropiridini
ES2183346T3 (es) Sistemas conjugados de bis-fosfonato con restos alquilantes que tienen actividad antitumoral.
CA2183745A1 (en) Detergent Compositions
FR2735361B1 (fr) Compositions contenant des vesicules lipidiques renfermant des nanopigments
MX9802136A (es) Composiciones detergentes.
UA30250A (uk) Антиоксидантний засіб